Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Macular Degeneration | 14 | 2023 | 958 | 3.420 |
Why?
|
Dark Adaptation | 5 | 2021 | 220 | 2.740 |
Why?
|
Retinal Diseases | 8 | 2022 | 664 | 2.190 |
Why?
|
Wet Macular Degeneration | 5 | 2023 | 141 | 2.120 |
Why?
|
Vitreous Body | 6 | 2018 | 388 | 1.340 |
Why?
|
Tomography, Optical Coherence | 22 | 2023 | 2514 | 1.320 |
Why?
|
Metabolomics | 7 | 2023 | 1421 | 1.310 |
Why?
|
Fluorescein Angiography | 22 | 2023 | 905 | 1.100 |
Why?
|
Fibrinolysin | 2 | 2016 | 133 | 1.080 |
Why?
|
Ophthalmology | 2 | 2021 | 491 | 1.000 |
Why?
|
Diabetic Retinopathy | 11 | 2023 | 1186 | 0.940 |
Why?
|
Choroidal Neovascularization | 6 | 2017 | 336 | 0.930 |
Why?
|
Choroid | 9 | 2018 | 309 | 0.900 |
Why?
|
Retina | 16 | 2022 | 2611 | 0.870 |
Why?
|
Visual Acuity | 15 | 2021 | 2474 | 0.810 |
Why?
|
Geographic Atrophy | 2 | 2019 | 61 | 0.750 |
Why?
|
Porphyrins | 7 | 2006 | 347 | 0.750 |
Why?
|
Retinal Necrosis Syndrome, Acute | 1 | 2020 | 22 | 0.740 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2021 | 205 | 0.740 |
Why?
|
Ophthalmologic Surgical Procedures | 2 | 2017 | 324 | 0.690 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2020 | 190 | 0.680 |
Why?
|
Light Coagulation | 1 | 2017 | 72 | 0.640 |
Why?
|
Photosensitizing Agents | 7 | 2006 | 606 | 0.640 |
Why?
|
Fatty Acids, Unsaturated | 2 | 2020 | 547 | 0.610 |
Why?
|
Eye Diseases | 2 | 2020 | 652 | 0.590 |
Why?
|
Photochemotherapy | 7 | 2006 | 812 | 0.590 |
Why?
|
Vitreous Detachment | 1 | 2016 | 22 | 0.590 |
Why?
|
Fibrinolytic Agents | 2 | 2016 | 2111 | 0.540 |
Why?
|
Eye Infections, Fungal | 1 | 2016 | 109 | 0.530 |
Why?
|
Retinal Drusen | 3 | 2021 | 65 | 0.510 |
Why?
|
Retinal Vessels | 9 | 2023 | 760 | 0.510 |
Why?
|
Vascular Endothelial Growth Factor A | 8 | 2023 | 3479 | 0.510 |
Why?
|
Endophthalmitis | 2 | 2016 | 258 | 0.500 |
Why?
|
Fungi | 1 | 2016 | 323 | 0.470 |
Why?
|
Telemedicine | 2 | 2021 | 2724 | 0.470 |
Why?
|
Phospholipase C gamma | 2 | 2011 | 127 | 0.470 |
Why?
|
Eye Infections, Bacterial | 1 | 2016 | 233 | 0.470 |
Why?
|
Proto-Oncogene Proteins c-cbl | 2 | 2011 | 120 | 0.460 |
Why?
|
Retinal Perforations | 2 | 2014 | 126 | 0.460 |
Why?
|
Metabolome | 2 | 2023 | 855 | 0.460 |
Why?
|
Peptide Fragments | 2 | 2016 | 5037 | 0.450 |
Why?
|
Lipids | 4 | 2022 | 3298 | 0.440 |
Why?
|
Ophthalmoscopes | 1 | 2012 | 23 | 0.430 |
Why?
|
Retinal Artery | 1 | 2012 | 112 | 0.400 |
Why?
|
Fundus Oculi | 8 | 2022 | 467 | 0.390 |
Why?
|
Nematode Infections | 1 | 2009 | 22 | 0.360 |
Why?
|
Retinitis | 1 | 2009 | 37 | 0.350 |
Why?
|
Eye Infections, Parasitic | 1 | 2009 | 23 | 0.350 |
Why?
|
Cross-Sectional Studies | 16 | 2023 | 24031 | 0.340 |
Why?
|
Vitrectomy | 4 | 2016 | 352 | 0.340 |
Why?
|
Retinal Detachment | 4 | 2018 | 392 | 0.340 |
Why?
|
Macular Edema | 3 | 2016 | 345 | 0.320 |
Why?
|
Artificial Intelligence | 1 | 2020 | 1969 | 0.310 |
Why?
|
Retinal Vein Occlusion | 2 | 2021 | 125 | 0.310 |
Why?
|
Retinal Neovascularization | 3 | 2021 | 248 | 0.300 |
Why?
|
Choroid Diseases | 3 | 2018 | 56 | 0.290 |
Why?
|
Intravitreal Injections | 3 | 2023 | 336 | 0.280 |
Why?
|
Angiography | 1 | 2012 | 1609 | 0.280 |
Why?
|
Microscopy, Confocal | 1 | 2012 | 1988 | 0.270 |
Why?
|
Bacteria | 1 | 2016 | 2117 | 0.270 |
Why?
|
Photoreceptor Cells, Vertebrate | 2 | 2018 | 206 | 0.260 |
Why?
|
Diagnostic Techniques, Ophthalmological | 2 | 2018 | 244 | 0.260 |
Why?
|
Prospective Studies | 17 | 2021 | 51869 | 0.250 |
Why?
|
Aged | 27 | 2023 | 161486 | 0.230 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5086 | 0.220 |
Why?
|
Macula Lutea | 2 | 2021 | 144 | 0.220 |
Why?
|
Neovascularization, Pathologic | 4 | 2023 | 2650 | 0.220 |
Why?
|
Epiretinal Membrane | 1 | 2022 | 68 | 0.220 |
Why?
|
Humans | 56 | 2023 | 725187 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3111 | 0.210 |
Why?
|
Blindness | 2 | 2023 | 610 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3221 | 0.210 |
Why?
|
Angiogenesis Inhibitors | 3 | 2023 | 2031 | 0.200 |
Why?
|
Macaca fascicularis | 8 | 2006 | 918 | 0.200 |
Why?
|
Vitreous Hemorrhage | 1 | 2021 | 43 | 0.200 |
Why?
|
Disease Models, Animal | 10 | 2019 | 18033 | 0.200 |
Why?
|
Middle Aged | 26 | 2023 | 212292 | 0.200 |
Why?
|
Portugal | 1 | 2020 | 86 | 0.190 |
Why?
|
Pandemics | 1 | 2020 | 7851 | 0.190 |
Why?
|
Fovea Centralis | 1 | 2020 | 116 | 0.190 |
Why?
|
Electrodes, Implanted | 1 | 2004 | 803 | 0.170 |
Why?
|
Body Fluids | 2 | 2019 | 307 | 0.170 |
Why?
|
Prosthesis Implantation | 1 | 2004 | 628 | 0.170 |
Why?
|
Myopia | 1 | 2021 | 254 | 0.170 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2020 | 228 | 0.170 |
Why?
|
Retinitis Pigmentosa | 1 | 2022 | 384 | 0.160 |
Why?
|
Exudates and Transudates | 2 | 2016 | 173 | 0.160 |
Why?
|
Female | 31 | 2022 | 375449 | 0.160 |
Why?
|
Receptors, Purinergic P2Y12 | 1 | 2018 | 123 | 0.160 |
Why?
|
Ocular Hypertension | 1 | 2019 | 193 | 0.150 |
Why?
|
Retinal Ganglion Cells | 3 | 2019 | 752 | 0.150 |
Why?
|
Photography | 3 | 2018 | 514 | 0.150 |
Why?
|
Area Under Curve | 1 | 2021 | 1661 | 0.150 |
Why?
|
Male | 31 | 2021 | 347096 | 0.150 |
Why?
|
Optic Disk | 2 | 2020 | 392 | 0.150 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2022 | 658 | 0.150 |
Why?
|
Visual Field Tests | 1 | 2019 | 371 | 0.150 |
Why?
|
Second Messenger Systems | 1 | 2017 | 209 | 0.150 |
Why?
|
Scleral Buckling | 2 | 2016 | 82 | 0.150 |
Why?
|
Iris | 1 | 1997 | 218 | 0.140 |
Why?
|
Prostheses and Implants | 1 | 2004 | 1362 | 0.140 |
Why?
|
Angiography, Digital Subtraction | 1 | 1997 | 357 | 0.140 |
Why?
|
Sensory Thresholds | 1 | 2017 | 397 | 0.140 |
Why?
|
Postoperative Complications | 2 | 2017 | 15019 | 0.130 |
Why?
|
Tissue Adhesions | 1 | 2016 | 232 | 0.130 |
Why?
|
Complement Pathway, Alternative | 1 | 2015 | 129 | 0.130 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2017 | 416 | 0.130 |
Why?
|
Retinal Pigment Epithelium | 1 | 2018 | 288 | 0.130 |
Why?
|
Republic of Korea | 1 | 2016 | 529 | 0.130 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 547 | 0.130 |
Why?
|
Dyslipidemias | 1 | 2022 | 842 | 0.120 |
Why?
|
Aged, 80 and over | 9 | 2019 | 57656 | 0.120 |
Why?
|
Capillary Permeability | 3 | 2005 | 827 | 0.120 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5522 | 0.120 |
Why?
|
Uveal Neoplasms | 1 | 2016 | 305 | 0.120 |
Why?
|
Follow-Up Studies | 6 | 2021 | 38748 | 0.110 |
Why?
|
Eye Injuries, Penetrating | 1 | 2014 | 103 | 0.110 |
Why?
|
Antibodies, Monoclonal | 3 | 2006 | 9245 | 0.110 |
Why?
|
Lipid Metabolism | 2 | 2022 | 1964 | 0.110 |
Why?
|
Visual Fields | 1 | 2019 | 1036 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2020 | 11413 | 0.100 |
Why?
|
Treatment Outcome | 6 | 2023 | 61761 | 0.100 |
Why?
|
Energy Intake | 1 | 2020 | 2148 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 2 | 2022 | 3800 | 0.100 |
Why?
|
Dietary Fats | 1 | 2020 | 2038 | 0.100 |
Why?
|
Vision Disorders | 1 | 2019 | 1035 | 0.100 |
Why?
|
Laser Coagulation | 2 | 2009 | 322 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2011 | 548 | 0.100 |
Why?
|
Chorioallantoic Membrane | 1 | 2010 | 45 | 0.100 |
Why?
|
Contrast Sensitivity | 2 | 2022 | 234 | 0.100 |
Why?
|
Microglia | 1 | 2018 | 1213 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2222 | 0.090 |
Why?
|
Cholesterol, HDL | 1 | 2016 | 1797 | 0.090 |
Why?
|
Animals | 19 | 2019 | 168714 | 0.090 |
Why?
|
Equipment Failure Analysis | 1 | 2012 | 851 | 0.090 |
Why?
|
Retrospective Studies | 10 | 2023 | 74206 | 0.080 |
Why?
|
Chick Embryo | 1 | 2010 | 991 | 0.080 |
Why?
|
Neoplasms, Second Primary | 1 | 2016 | 1024 | 0.080 |
Why?
|
Case-Control Studies | 4 | 2018 | 21591 | 0.080 |
Why?
|
Enzyme Activation | 2 | 2011 | 3739 | 0.080 |
Why?
|
Longitudinal Studies | 2 | 2021 | 13698 | 0.080 |
Why?
|
Indocyanine Green | 2 | 1999 | 235 | 0.070 |
Why?
|
Cholesterol, LDL | 1 | 2016 | 2318 | 0.070 |
Why?
|
Intraocular Pressure | 3 | 2020 | 1171 | 0.070 |
Why?
|
Life Style | 1 | 2018 | 3780 | 0.070 |
Why?
|
Liposomes | 3 | 1999 | 770 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 11968 | 0.070 |
Why?
|
Endothelial Growth Factors | 2 | 2000 | 697 | 0.070 |
Why?
|
Choroid Neoplasms | 1 | 2006 | 171 | 0.070 |
Why?
|
Risk Factors | 6 | 2018 | 71009 | 0.070 |
Why?
|
Lymphokines | 2 | 2000 | 954 | 0.070 |
Why?
|
Ciliary Body | 1 | 2006 | 173 | 0.070 |
Why?
|
Injections | 2 | 2006 | 839 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2018 | 3908 | 0.070 |
Why?
|
Software | 1 | 2019 | 4406 | 0.070 |
Why?
|
Mice, Inbred C57BL | 6 | 2019 | 22134 | 0.070 |
Why?
|
Endothelium, Vascular | 3 | 2011 | 4515 | 0.070 |
Why?
|
Burkitt Lymphoma | 1 | 2006 | 360 | 0.060 |
Why?
|
Mass Screening | 1 | 2020 | 5197 | 0.060 |
Why?
|
Blood Vessels | 1 | 2010 | 1130 | 0.060 |
Why?
|
Adult | 11 | 2022 | 211615 | 0.060 |
Why?
|
Aorta, Thoracic | 1 | 2010 | 1054 | 0.060 |
Why?
|
Glaucoma | 2 | 2019 | 1034 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5059 | 0.060 |
Why?
|
Comorbidity | 1 | 2018 | 10247 | 0.060 |
Why?
|
Equipment Design | 1 | 2012 | 3564 | 0.060 |
Why?
|
Macrophages | 1 | 2018 | 5689 | 0.060 |
Why?
|
United States | 4 | 2020 | 68403 | 0.060 |
Why?
|
Retinal Degeneration | 2 | 2019 | 403 | 0.060 |
Why?
|
Chronic Disease | 1 | 2018 | 9022 | 0.060 |
Why?
|
Logistic Models | 1 | 2018 | 13358 | 0.060 |
Why?
|
Cell Division | 1 | 2011 | 4604 | 0.060 |
Why?
|
Safety | 2 | 2005 | 1189 | 0.050 |
Why?
|
Blotting, Western | 1 | 2010 | 5236 | 0.050 |
Why?
|
Diet | 1 | 2020 | 7797 | 0.050 |
Why?
|
Ischemia | 2 | 2023 | 1911 | 0.050 |
Why?
|
Cell Death | 2 | 2018 | 1705 | 0.050 |
Why?
|
Time Factors | 3 | 2021 | 40186 | 0.050 |
Why?
|
Phenotype | 1 | 2018 | 16272 | 0.050 |
Why?
|
Enzyme Inhibitors | 2 | 2010 | 3822 | 0.050 |
Why?
|
Body Mass Index | 1 | 2018 | 12523 | 0.050 |
Why?
|
Swine | 1 | 2010 | 5888 | 0.050 |
Why?
|
Mice | 8 | 2019 | 80300 | 0.050 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2000 | 227 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15442 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 13765 | 0.040 |
Why?
|
Carrier State | 1 | 2022 | 516 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2006 | 6460 | 0.040 |
Why?
|
Retinal Vein | 1 | 1997 | 47 | 0.040 |
Why?
|
Dextrans | 1 | 2000 | 590 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2019 | 3693 | 0.040 |
Why?
|
Melanoma | 1 | 2016 | 5358 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2011 | 19485 | 0.040 |
Why?
|
Atrophy | 1 | 2022 | 1514 | 0.040 |
Why?
|
GTP-Binding Proteins | 1 | 2022 | 977 | 0.040 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 1997 | 149 | 0.040 |
Why?
|
Prosthesis Design | 1 | 2004 | 2089 | 0.040 |
Why?
|
Microvessels | 1 | 2021 | 547 | 0.040 |
Why?
|
Epoxide Hydrolases | 1 | 2017 | 118 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14721 | 0.040 |
Why?
|
Mice, Knockout | 2 | 2010 | 14769 | 0.040 |
Why?
|
Young Adult | 3 | 2018 | 55781 | 0.030 |
Why?
|
Prognosis | 1 | 2016 | 28737 | 0.030 |
Why?
|
Hyperoxia | 1 | 1997 | 258 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2016 | 208 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2216 | 0.030 |
Why?
|
Infusions, Intravenous | 2 | 1999 | 2260 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2004 | 1699 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2018 | 9789 | 0.030 |
Why?
|
Visual Perception | 1 | 2004 | 1412 | 0.030 |
Why?
|
Coloring Agents | 1 | 1997 | 556 | 0.030 |
Why?
|
Eye Infections | 1 | 2014 | 63 | 0.030 |
Why?
|
Nitric Oxide Synthase | 1 | 1997 | 919 | 0.030 |
Why?
|
Pigment Epithelium of Eye | 1 | 2014 | 230 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2012 | 19624 | 0.030 |
Why?
|
Lens Capsule, Crystalline | 1 | 1992 | 43 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2019 | 11484 | 0.030 |
Why?
|
Drug Substitution | 1 | 2015 | 275 | 0.030 |
Why?
|
Laser Therapy | 1 | 1999 | 1047 | 0.030 |
Why?
|
Drug Carriers | 1 | 1996 | 686 | 0.030 |
Why?
|
Uveitis | 1 | 2014 | 373 | 0.020 |
Why?
|
Cell Survival | 2 | 2018 | 5914 | 0.020 |
Why?
|
SEER Program | 1 | 2016 | 1514 | 0.020 |
Why?
|
Observer Variation | 1 | 2016 | 2610 | 0.020 |
Why?
|
Light | 1 | 1996 | 1397 | 0.020 |
Why?
|
Blood Pressure | 2 | 2016 | 8475 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2614 | 0.020 |
Why?
|
Leukocytes | 1 | 2017 | 2057 | 0.020 |
Why?
|
Cell Count | 2 | 2006 | 1871 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 5087 | 0.020 |
Why?
|
Incidence | 2 | 2016 | 20750 | 0.020 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2000 | 775 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3877 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2015 | 4758 | 0.020 |
Why?
|
Tyrosine | 1 | 2011 | 1471 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 14992 | 0.020 |
Why?
|
Tonometry, Ocular | 1 | 2006 | 226 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2006 | 8657 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 3296 | 0.020 |
Why?
|
Regression Analysis | 1 | 2015 | 6432 | 0.020 |
Why?
|
Mice, Inbred DBA | 1 | 2006 | 651 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2006 | 646 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6227 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2022 | 7921 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2017 | 3389 | 0.020 |
Why?
|
Antigens, CD | 1 | 2015 | 4052 | 0.020 |
Why?
|
Gene Expression | 1 | 1997 | 7819 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 3992 | 0.020 |
Why?
|
Adolescent | 3 | 2016 | 84401 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9839 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1997 | 13044 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2006 | 12870 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2006 | 2801 | 0.010 |
Why?
|
Neoplasms | 1 | 2011 | 20941 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2006 | 1855 | 0.010 |
Why?
|
Blood Glucose | 1 | 2016 | 6217 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 5891 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12329 | 0.010 |
Why?
|
HIV Seropositivity | 1 | 2006 | 939 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7683 | 0.010 |
Why?
|
Genotype | 1 | 2015 | 12902 | 0.010 |
Why?
|
Cytokines | 1 | 2014 | 7180 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 8487 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12935 | 0.010 |
Why?
|
Retreatment | 1 | 1999 | 607 | 0.010 |
Why?
|
Molecular Weight | 1 | 2000 | 2327 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2000 | 1442 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 1997 | 255 | 0.010 |
Why?
|
Retinal Artery Occlusion | 1 | 1997 | 65 | 0.010 |
Why?
|
N-Methylaspartate | 1 | 1997 | 234 | 0.010 |
Why?
|
Microspheres | 1 | 2000 | 785 | 0.010 |
Why?
|
Optic Nerve Diseases | 1 | 1999 | 309 | 0.010 |
Why?
|
Optic Nerve | 1 | 1999 | 554 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1997 | 1598 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 39918 | 0.010 |
Why?
|
Infant | 1 | 2016 | 34337 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 10971 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17354 | 0.010 |
Why?
|
Child, Preschool | 1 | 2016 | 40440 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 34776 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 19908 | 0.010 |
Why?
|
Lenses, Intraocular | 1 | 1992 | 138 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1997 | 1895 | 0.010 |
Why?
|
Cataract Extraction | 1 | 1992 | 468 | 0.010 |
Why?
|
Child | 1 | 2016 | 75163 | 0.010 |
Why?
|
RNA | 1 | 1997 | 2718 | 0.000 |
Why?
|
Signal Transduction | 1 | 2011 | 23448 | 0.000 |
Why?
|
Oxygen | 1 | 1997 | 4143 | 0.000 |
Why?
|